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One figure is available online.doi:10.1016/j.jtcvs.2004.10.022Background: Methods for obtainingreal-time in vivo histologic resolution by means
of noninvasive endoscopic optical imaging would be a major advance for thoracic
surgical diagnostics and treatment. Optical coherence tomography is a rapidly
evolving technology based on near-infrared interferometry that might provide these
capabilities. The purpose of this study is to investigate the feasibility of real-time 2-
and 3-dimensional optical coherence tomographic imaging of airway, pleural, and
subpleural lung tissues in normal, inflammatory, and malignant animal models and
patients with known or suspected airway malignancy.
Methods: Freshly excised lungs and pleural tissue obtained from rabbits with
inhalation lung injury and induced empyema, metastatic sarcomas, and pleural
sarcomas and from patients with airway disease were imaged by using 2- and
3-dimensional optical coherence tomography with a prototype superluminescent
diode optical coherence tomographic system constructed in our laboratory. Lungs
and pleural tissue were subsequently processed for standard hematoxylin and eosin
histology for comparison with optical coherence tomography.
Results: Optical coherence tomographic imaging achieved an ex vivo resolution of
10 m and an in vivo resolution of about 30 m with a depth penetration of 1 to
2 mm with 2- and 3- dimensional reconstruction capabilities. Tumors as small as
500 m were detectable with optical coherence tomography. The acquired images
closely matched histologic images, demonstrating details at the level of mucosal
layers, glands, alveoli, and respiratory bronchioles.
Conclusions: Optical coherence tomography with near-infrared interferometric
methods enables near real-time in vivo near-histologic resolution optical imaging. With
further advances, optical coherence tomography has the potential for real-time accurate
and early pleural and subpleural diagnostics by using small-diameter flexible fiberoptic
endoscopic probes for a wide range of thoracic surgical applications.
During bronchoscopy or endoscopy or while in the operating room,the ability to distinguish benign from malignant disease and todetermine the extent of lesion margins is critical for successfulinterventions. In addition, rapid and accurate evaluation of airwaypathologic changes is important for minimizing morbidity andmortality in other conditions, such as acute burn or inhalation
injury.1,2 Until now, assessment for proper clinical management relied primarily on
visualization of abnormalities during endoscopic biopsy on frozen sections sent to
pathology and gross inspection at the time of surgical intervention. A means to
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ETobtain real-time noninvasive histologic imaging would aid
in diagnosis, help to ensure higher-yield biopsy samples,
potentially save considerable operating time, and possibly
help avoid unnecessary interventions or repeated proce-
dures.
Optical coherence tomography (OCT) is emerging as a
rapid-acquisition, high-resolution imaging modality that
provides capabilities for real-time near-histologic evalua-
tion.3 In attempting to approach the concept of optical
biopsy,4 OCT offers the potential for surface and subsurface
optical imaging (up to a depth of 1-2 mm) with high spatial
resolution of tissue microstructure without requiring contact
between the optical probe and the tissue sample.3 Tissue
layers, glands, small blood vessels, and cartilage can be
visualized at theoretic resolutions approaching 10 m with
the use of superluminescent diode (SLD) laser prototype
systems.5 This technology, in combination with minimally
invasive techniques, can be applied in the surgical field to
examine tissue microstructure, guide biopsies, and mini-
mize the need for frozen sections or the uncertainties asso-
ciated with gross examination.6 Additionally, multiple se-
quential high-resolution images can be captured, rendered,
and integrated to form 3-dimensional images.7
We developed a fiberoptic OCT probe (1 mm in diame-
ter) for bronchoscopic and thoracoscopic application to as-
sess the feasibility of OCT imaging in inflammatory and
neoplastic changes of the airway and lung parenchyma, as
well as of visceral and parietal pleural tumors, induced by a
novel pleural malignancy animal model developed in our
laboratory. Two- and 3-dimensional OCT images were con-
structed. This technology was then applied to patients with
known or suspected airway malignancy.
Materials and Methods
Animal Preparation
Anesthesia and intubation. Male New Zealand White rabbits
(Myrtle Rabbitry Inc, Thompson Station, Tenn) weighing 4.0 
0.4 kg were anesthetized with a ratio of ketamine HCI (100
mg/mL, Ketaject; Phoenix Pharmaceutical Inc, St Joseph, Mich)
and xylazine (20 mg/mL, Anased; Lloyd Laboratories, Shenan-
doah, Iowa) at a dose of 0.75 mL/kg administered intramuscularly.
Maintenance anesthesia was administered (0.3 mL of a 1:1 mixture
of ketamine/xylazine) through the marginal ear vein. Animals were
intubated with a 3.0 endotrachael tube and mechanically ventilated
(Harvard Apparatus dual-phase control respirator, South Natick,
Mass). Animal protocols were approved by the Animal Research
Committee (IACUC no. 2001-2272 and 2002-2397).
Airway injury and empyema induction. Twelve animals were
inoculated with 1.9  103 to 2.4  105 Streptococcus pneumoniae
cells by using a sterile pediatric suction catheter in accordance
with an approved protocol from the Institute of Surgical Research,
San Antonio, Tex.8 Animals were monitored on the basis of vital
signs, blood work, and pulmonary function tests at the time of and
after 24, 48, 72, and 96 hours of exposure. Computed tomographic
scans, flow cytometry, and bronchoalveolar lavage fluid culture
were performed to confirm the diagnosis of pneumonia. On the
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their tracheas were excised, placed in isotonic saline, packed on
ice, and sent overnight to the Beckman Laser Institute. All samples
were imaged within 3 days of excision. Empyemas were induced
in a New Zealand White rabbit, as previously described.9 In brief,
2 mL of 108 Pasteurella multocida bacteria (in 0.5% Brain Heart
Infusion agar) was injected into the right pleural space. Twenty-
four hours after induction, pleural fluid from a diagnostic thora-
centesis was cultured and analyzed for pH and glucose to verify
the presence of empyema. After day 6 of induction and after the
animals were sacrificed, the thorax was dissected en bloc, and
specimens from the right middle lobe with attached visceral pleura
were collected. These specimens were frozen at 20°C until the
time of OCT imaging.
Pleural and parenchymal tumor implantation. After intuba-
tion, a 4-mm thoracoscope (Karl Storz, Tuttlingen, Germany) was
inserted under sterile conditions in the fifth or sixth intercostal
spaces of 12 New Zealand White rabbits, and with thoracoscopic
visualization, a small section of the chest wall parietal pleura was
mildly abraded with the wooden end of a sterile cotton-tip appli-
cator. A syringe containing a dose of 10 to 13 million VX2
sarcoma tumor cells (M.D. Anderson Cancer Center, University of
Texas, Houston, Tex) excised and prepared for suspension from
rabbits with primary tumors was used to inject the cells into the
chest cavity adjacent to the abraded pleural surface.
Hematogenous tumor implantation. Hematogenous lung me-
tastases were induced either by means of direct intravenous injec-
tion of the tumor cells into the rabbit ear vein or by means of
intramuscular injection into the left thigh (10-15 million cells) in
12 New Zealand White rabbits. Hematogenous tumor spread to the
lungs generally occurred 2 to 4 weeks after intravenous or intra-
muscular injection.
OCT and Flexible Fiberoptic Probe Prototype
OCT theory has been discussed in detail in previous studies.3 in
brief, OCT uses a broadband near-infrared light source in which
the emitted light is split into sample and reference beams. The
reflected waveforms combine to create an interference pattern
(Figure E1, a). A low temporal coherence SLD light source (cen-
tral wavelength o  1300 nm and full width at half maximum 
  80 nm; AFC Technologies, Hull, Quebec, Canada) is con-
nected to a Michelson interferometer that splits the light source
into a sample and reference beam. These reflected beams recom-
bine at the fiber coupler in the interferometer, producing the
interference pattern detected by a photomultiplier.
Signal processing and data acquisition are accomplished with
the use of a computer. Cross-sectional images were constructed by
repeating the measurements at adjacent points along a sampling
line. Imaging depth was approximately 1 to 2 mm. Because the
OCT light source is not visible, an aiming beam (laser diode with
  650 nm) was coupled to the system to elucidate the location
of the sampling site.
Flexible fiberoptic OCT probes (Figure E1, b) were constructed
from single-mode fiber patch cord (ThorLabs, Newton, NJ). The
bare-ended fiber was attached to a 0.5-mm-diameter GRIN lens
(NSG America, Irvine, Calif) with optical adhesive (Optical Ad-
hesive no. 68; Norland Products, Cranbury, NJ) under a micro-
scope. A right-angle light path was achieved by using a 0.5-mm
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ETprism.10 The probe was placed in FEP tubing (17-gauge thin wall;
Zeus, Orangeburg, SC) for added fiber support.
Tracheal and Lung OCT
Tracheal OCT. After anesthesia induction and intubation, the
trachea was exposed by means of blunt dissection so that local-
ization of OCT sampling could be determined. A flexible fiberoptic
probe was inserted into the endotracheal tube. The visible laser
light emitted from the probe confirmed the segment of trachea
under OCT investigation, and OCT images were obtained. After
animal death, the trachea was removed. Twelve excised tracheas
were cut open longitudinally along their musculofibrous mem-
branes and divided into approximately 29 sections of 2 cm in
length. Triangular notches were cut into the opposite ends of each
specimen to delineate the line of image acquisition perpendicular
to the cartilage rings (Figure 1, b). The tracheas were secured to
pieces of cork by using metal pins placed along their perimeter and
covered by a layer of KY jelly to prevent desiccation during
imaging. The tracheas were placed on a moveable sample plat-
form, and a visible-light guiding beam was used to match the line
Figure 1. In vivo endoscopic image (a) of a normal rab
mm outer diameter endotracheal tube). Cartilage (C), l
Bar  1.0 mm. Schematic of tracheal specimen prepara
corresponding standard H&E histology (d). Inhalation i
histology (f). Cartilage (C), submucosal glands (SG),
distinguishable in both OCT and histologic images (eof image acquisition with the triangular marking notches.
The Journal of ThoraciAnimal lung OCT. Normal, inflamed, and malignant tissue
imaging was performed on both in vivo and excised tissue. In vivo
animal studies were performed as follows. After anesthesia induc-
tion and intubation, while using standard sterile surgical proce-
dures, a 4-mm thoracoscope was inserted into the left side of the
chest to inspect the visceral and parietal pleura for pathologic
tissue changes. If abnormal tissue structure was observed, a second
trocar was inserted under direct visualization, and a 1-mm-diam-
eter flexible fiberoptic OCT probe was placed over the suspected
lung or chest wall pathology for OCT imaging. Once it was
believed that the probe was in the proper place, the ventilator was
paused briefly, and images were captured. After completion of the
studies, the animal was sacrificed, a median sternotomy was per-
formed, and the tissue was excised for histologic examination.
Two- and 3-dimensional OCT. OCT images were performed
on 8 excised tissues from rabbits and purchased pig lungs during
the probe developmental stage in a similar fashion to images
performed during in vivo studies. Specimens were mounted on
cork board, and by using a 4 objective attached to a servo motor,
rachea through an endotracheal tube (cuff number 3.0
a propria (LP), and submucosa (SM) can be observed.
(b). Normal control rabbit trachea OCT image (c), with
tracheal image (e), with corresponding standard H&E
na propria (LP), and submucosa (SM) thickening is
). Bar  0.5 mm.bit t
amin
tion
njurythe coherent laser light source was focused through the lens and
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Figure 2. Normal pig lung OCT (a), with corresponding standard H&E (b). Alveoli (A) and pleura (P) can be identified
in both OCT and histologic images. Bar  0.5 mm. Images of normal rabbit lung by OCT (c) and corresponding
standard H&E (d). As with pig lung, alveoli (A) and pleura (P) can be identified by means of both OCT and histology.
Bar  0.5 mm. OCT image of rabbit lung infected with Pasteurella species (e) and corresponding H&E (f)
demonstrated pleural thickening and a lack of alveoli structures caused by purulent lung tissue. Bar  0.5 mm. In
h
Tumor margin 
Lung Parenchyma vivo OCT of rabbit lung with metastatic disease without (g) and with (h) labels. Bar  0.5 mm.
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ETscanned over the tissue. The specimen was advanced along the
x-axis 20 or 40 m (depending on desired resolution) after each
single lateral pass on the y-axis to accomplish 3-dimensional OCT.
Three-dimensional images of OCT and histology sections were
constructed with the aid of a software package (3D Doctor; Able
Software Corp, Lexington, Mass). The time to scan a 3-mm3 (1 
3 mm) tissue was approximately 20 minutes.
Human Airway OCT Imaging
During clinical bronchoscopies in patients with known or sus-
pected airway disease, the flexible fiberoptic probe was inserted
through the working channel of the bronchoscope. The suspicious
region was imaged with OCT. If clinically indicated, a biopsy was
performed at the imaged site and prepared in the standard manner
for histologic analysis. Human studies were approved by the
institutional review board (no. 2003-2907). Informed consent was
obtained before bronchoscopic procedures.
Histology
Histology of excised tissue was prepared according to standard he-
matoxylin and eosin (H&E) histologic staining methods. OCT images
and those of the histologic sections were compared. Tissue slide
examination and micrographs were performed with an Olympus BH2
light microscope (Olympus American, Melville, NY) and recorded
with an Olympus DP10 camera (Olympus American) for a light
microscope and Olympus Digital Microfire 1.0 (Olympus American).
Results
By using the SLD prototype OCT system, 14-mm  1.3-mm
airway images were acquired and displayed in near real-time
on a computer screen. High-resolution images of normal and
diseased trachea, as well as normal control lung, malignant
parenchymal lung tumor, visceral, parietal, and diaphragmatic
a
b
 c 
T
    O 
A
P
Figure 3. Histologic images of a single (a) and multip
images of subpleural tumors (T) with (b and e) and wi
pleural (P) surface when imaged thoracoscopically. Bpleural tumor specimens, were obtained by using OCT. These
The Journal of Thoraciimages revealed levels of resolution capable of clearly identi-
fying airway structures, pleura, and alveoli.
Although there was variability within samples from each
image, marked differences between the normal lungs and
pleura compared with the malignant samples were clearly
visualized with OCT. Changes ranged from loss of structure
to variations in tissue thickness.
Tracheal OCT
In vivo endoscopic OCT images displayed tracheal struc-
tures visible even through the endotracheal tube (Figure 1,
a). Clear anatomy of mucosal, submucosal, and cartilage
layers are seen.
OCT images and the corresponding histology sections are
shown in Figure 1, c and d, and Figure 1, e and f, for both
normal and inflamed trachea, respectively. Tracheal cartilage
(Figure 1, c) was an identifiable landmark seen during OCT
imaging, which was confirmed with histology. OCT images
were able to distinguish the submucosa from the lamina pro-
pria. Also observed in both OCT mapping and histology sec-
tions were submucosal glands between cartilage rings. A slight
variation in tissue structure occurred, with decreased submu-
cosal layer thickness in the histologic specimens, which was
believed to have resulted from tissue property desiccation
changes after excision and fixation. Injured trachea obtained
from animals inoculated with S pneumoniae demonstrated a
thickened submucosa that was seen in both OCT imaging and
histology (Figure 1, e and f).
Lung and Pleural OCT
OCT imaging of lung tissue was able to detect structures as
  d
  e
 f 
T T
 O
) metastatic sarcoma nodules in a rabbit model. OCT
(c and f) labels. Placement of probes (O) flattens the
1.0 mm.le (d
thoutfine as alveolar septa and visceral pleura. Figure 2, a and b,
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Figure 4. Gross specimen (a) of chest wall parietal pleural tumor (T). Tumor nodules were interdispersed between ribs (R)
and intercostal muscle (IM). OCT of visceral pleural tumor originating from pleural space (b). Detection of a continuous
pleural line (arrows) suggests in situ growth without invasion across adjacent tissue. Bar  1.0 mm. Histology (c) and OCT
(d) of chest wall parietal pleural tumor (T). Shadowing of the tumor occurs when high absorption-reflection surfaces
effectively block further penetration of light interference below them. Gross specimen (e) of lung visceral pleural tumor (T).
Notable variations in tumor growth were apparent. Bar  5.0 mm. OCT of visceral pleural tumor (f). Absence of pleural line
below tumor suggests hematogenous origin of this metastatic tumor. Bar  0.5 mm. Three-dimensional histology (g and i)
and OCT (h and j). Three-dimensional reconstruction of histology and OCT shows 2 tumor nodules (T) and normal tissue
i.   j. 
T T
 T 
T
Awhere alveoli (A) can be identified. Bar  0.5 mm.
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ETand Figure 2, c and d, show comparisons between OCT and
histology of normal pig and rabbit lung specimens, respec-
tively. In Figure 2 alveoli and visceral pleura were discern-
ible. OCT images of pig lung are superior to those of rabbit
lung, possibly because of the finer structures in the rabbit
lung. However, in the rabbit lung tissue with induced bac-
terial empyema (Figure 2, e) and metastatic disease (Figure
2, g and h), these structures were no longer distinguishable
because of thickening of the pleura and filling of the alveoli
with purulent material (Figure 2, f) and the compression of
adjacent tissues by lung tumor Figure 3.
In vivo thoracoscopic examination revealed subpleural
tumors (Figure 3), although detection of lung malignancies
at increasing tissue depth (2-3 mm) was not possible.
Lung tumors as small as 500 m (Figure 4, e), which were
difficult to detect by means of gross examination, could be
observed with OCT (Figure 4, f).
Small parietal (Figure 4, a, c, and d) and visceral (Figure
4, b, and e) pleural-based tumors that had not invaded the
parenchyma could be characterized by means of visualiza-
tion of the pleural line below the nodule (Figure 4, b). In
contrast, small hematogenous tumor metastases that formed
below the pleural surface showed very different character-
istics on OCT (Figure 4, f).
Three-Dimensional Imaging of OCT
In selected specimens 3-dimensional reconstructions were pre-
pared and analyzed for comparison with 3-dimensional histol-
ogy. Although some differences caused by fixation of the
histologic slide tissues were noted, both OCT and histologic
3-dimensional images demonstrated very similar appearance.
Figure 4, g through j, shows 3-dimensional relationships be-
tween OCT images and histologic preparations.
Human Airway
Two patients with and without airway disease who provided
informed consent (protocol HS#2003-2907) underwent clin-
ical flexible fiberoptic bronchoscopies with OCT. The OCT
probe was passed through the working port of the flexible
fiberoptic bronchoscope, and OCT images were obtained of
the intrabronchial lesions. Lateral scanning sampling reso-
lution averaged 20 to 30 m in the lung. Images showed
changes in airway structure in malignant airway regions
when compared with normal tissue. Pathologic changes
noted on OCT consisted of a thickened mucosa and disor-
ganization of tracheal tissue layers when compared with
sections of normal tissue. Corresponding OCT and white-
light bronchoscope images of inflamed tissues obtained
during bronchoscopy are shown in Figure 5.
Discussion
These studies confirm the feasibility of high-resolution OCT
imaging of the airway and pleura for evaluating distal
The Journal of Thoraciairway, lung, and pleural pathology to obtain optical images
at near-histologic levels in vivo. Differences in tissue layers
of the airway and pleura were clearly distinguishable and
corresponded closely to standard H&E images subsequently
obtained from the excised tissues. OCT images could be
obtained in near real time in vivo with the use of flexible
fiberoptic probes and applied to the clinical setting. To our
knowledge, this is the first report of high-resolution, in vivo,
bronchoscopic OCT imaging in diseased human bronchi
imaged by means of OCT during flexible fiberoptic bron-
choscopy. Previous medical applications exploring the use
of OCT have been investigated in the fields of ophthalmol-
ogy, gastroenterology, and cardiology.11-16 There are many
areas of thoracic clinical diagnosis in which OCT might
become useful as resolution improves. Recent studies in our
own and affiliated laboratories8 have demonstrated OCT
capabilities in proximal airways in ex vivo specimens. With
the availability of in vivo high-resolution optical capabili-
a                                                                                                                                           
b
c.
Mucosal surface
Cartilage
OCT probe 
Figure 5. Image (a) of an OCT probe (O) within a human airway
(right upper lobe bronchus) obtained through a flexible fiber
bronchoscope. In vivo OCT image of an inflamed right upper lobe
bronchus without (b) and with (c) labels.ties, responses to therapy in thoracic diseases might be
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rent level of actual resolution (10-20 m), tissue layers, mu-
cosa, and airway epithelium were visualized. Architectural
disruptions in diseased tracheal specimens (Figure 1, d) clearly
demonstrated an increase in mucosal thickness that suggested
underlying tissue damage. In airway inhalation injury delinea-
tion of submucosal edema, hyperemia, and blood flow changes
by OCT (including use of optical Doppler tomographic tech-
niques)17 could become a significant adjunct to bronchoscopy
for the management of tracheal and bronchial injury.
Histologic examination of bronchial mucosa during flex-
ible or rigid bronchoscopic procedures could greatly assist
in the diagnosis and localization of endobronchial malig-
nancy. This might be particularly useful in malignancies
such as adenoid cystic carcinomas in which tumor spread
tends to occur in the submucosal plane well beyond the
observed luminal component of the tumor. Application of
OCT in this and similar settings would allow for possible
detection of hidden margins (Figure 2, g) that might other-
wise be missed in gross examination and could assist with
guiding resection margins, as well as assessing operability.
Tissue structural changes strongly suggestive of malignant
tumor invasion could be detected at resolution of the current
SLD OCT system (Figure 4). However, improvement in res-
olution to 1 to 2 m will be required to visualize nuclei and
organelles to definitively differentiate malignant transforma-
tion optically at a cellular level. Such improvements in reso-
lution might be achievable in the near future by using broad-
band light sources, polarization-sensitive OCT (PS-OCT), and
multiphoton microscopy combined with OCT.18
The ability to visualize tissue structures in real time at a
near-histologic level of resolution opens up a wide range of
potential areas for clinical and research applications in
thoracic surgery. In the future, when cellular-level OCT
resolutions are obtained, even greater uses for OCT in
thoracic diagnostics can be envisioned. However, the depth
of penetration of OCT is relatively shallow (1-2 mm) and is
likely to remain limited by the degree of scattering inherent
in complex biologic tissues of the lung and thorax, and thus
major advances in depth of penetration are unlikely. Nev-
ertheless, there are many scenarios in thoracic surgery in
which surface and near-surface, in vivo, high-resolution
optical imaging are of great potential value.
The development of 3-dimensional high-resolution OCT
probes, endoscopes, and image-processing and display tech-
nologies might allow for improved assessment of tumor
margins and detection of satellite lesions. Further into the
future, very small OCT probes could be designed to fit
within needles to allow imaging at depths within masses
with near real-time histologic resolution capabilities.
This study has demonstrated the feasibility of high-
resolution 2- and 3-dimensional OCT for examination of tho-
racic airway and pleural abnormalities. There are a range of
622 The Journal of Thoracic and Cardiovascular Surgery ● Marpotential research and clinical applications for OCT imaging in
thoracic surgery and diagnostics. The technology used in this
study is limited to 10- to 30-m resolutions, and depth of
penetration is generally a maximum of 2 to 3 mm. With further
improvement in resolution, contrast, acquisition, display, and
processing and the development of specific thoracic probes,
OCT might offer a significant advance for the diagnosis and
treatment of patients with thoracic diseases.
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Figure E1. a, OCT schematic. Light from a coherent broadband source is coupled with an aiming beam at an
inverted 2 1 beam splitter. The beam is split at the Michelson interferometer into reference and sampling beams.
The reflected wave forms are then recombined at the interferometer, digitally processed, and displayed as a gray
scale map. b, Translational endoscopic OCT probe for in vivo imaging. A prism and lens are attached to
single-mode fiber. The distal end of the fiber is attached to a linear motor, and the proximal end of the probe is
enclosed in tubing with an outside diameter of 2.0 mm.
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